Cargando…
Nicotinamide Mononucleotide Administration Prevents Experimental Diabetes-Induced Cognitive Impairment and Loss of Hippocampal Neurons
Diabetes predisposes to cognitive decline leading to dementia and is associated with decreased brain NAD(+) levels. This has triggered an intense interest in boosting nicotinamide adenine dinucleotide (NAD(+)) levels to prevent dementia. We tested if the administration of the precursor of NAD(+), ni...
Autores principales: | Chandrasekaran, Krish, Choi, Joungil, Arvas, Muhammed Ikbal, Salimian, Mohammad, Singh, Sujal, Xu, Su, Gullapalli, Rao P, Kristian, Tibor, Russell, James William |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7313029/ https://www.ncbi.nlm.nih.gov/pubmed/32466541 http://dx.doi.org/10.3390/ijms21113756 |
Ejemplares similares
-
Nicotinamide Mononucleotide Administration Prevents Doxorubicin-Induced Cardiotoxicity and Loss in Physical Activity in Mice
por: Margier, Marielle, et al.
Publicado: (2022) -
Oral Administration of Nicotinamide Mononucleotide Increases Nicotinamide Adenine Dinucleotide Level in an Animal Brain
por: Ramanathan, Chidambaram, et al.
Publicado: (2022) -
Subacute Toxicity Study of Nicotinamide Mononucleotide via Oral Administration
por: You, Yingnan, et al.
Publicado: (2020) -
Administration of nicotinamide mononucleotide improves oocyte quality of obese mice
por: Wang, Luyao, et al.
Publicado: (2022) -
Nicotinamide Mononucleotide Administration Amends Protein Acetylome of Aged Mouse Liver
por: Luo, Chengting, et al.
Publicado: (2022)